Ivy Rx vs Wisp
Wisp costs $76 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Ivy Rx
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Ivy Rx →
If you are choosing between Ivy Rx and Wisp, the first difference is cost: Wisp is $76 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Ivy Rx leads our six-part score, 7.3 to 6.5.
Ivy Rx vs Wisp price
Wisp is the cheaper way in: $99 a month against $175 a month at Ivy Rx. That is $76 less each month (43% lower), or about $912 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Ivy Rx ($175 a month vs $225 a month); tirzepatide is cheaper at Wisp ($99 a month vs $275 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Ivy Rx prices compounded injections, while Wisp prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Wisp is the only one of the two with a brand-name price.
Where each one treats patients
Ivy Rx lists 50 states, and Wisp does not publish where it ships.
Pricing
Ivy Rx
Range up to $197/mo
Range up to $297/mo
Wisp
Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.
Zepbound $99/mo (compounded sublingual semaglutide $225/mo)
What each price covers
Both prices cover the medication itself and shipping.
Ivy Rx's price also covers the clinician visit, which Wisp does not claim.
Ivy Rx is silent on lab work and coaching.
Wisp is silent on the clinician visit, lab work and coaching.
Ivy Rx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Wisp
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Ivy Rx scores 7.3 and Wisp 6.5 out of 10.
Ivy Rx is stronger on trust & safety (7.5 vs 6.5), accessibility (10.0 vs 5.0) and support (7.0 vs 4.5).
Wisp is stronger on value (3.5 vs 3.0).
Effectiveness and user experience are within half a point.
Ivy Rx
7.3/10
Wisp
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Ivy Rx nor Wisp has an FDA warning letter on record with us.
Features & Coverage
| Feature | Ivy Rx | Wisp |
|---|---|---|
| Starting Price | $175/mo | ✓$99/mo |
| Features | 3 features | ✓8 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Ivy Rx
Ivy Rx is a telehealth seller running tiered compounded semaglutide and tirzepatide programs.
Read our full Ivy Rx review →About Wisp
$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.
Read our full Wisp review →Pros & Cons
Ivy Rx
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Ivy Rx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Wisp
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to Wisp
Watch-outs
- Semaglutide costs $225 a month, 22% above the $184 median for compounded semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Ivy Rx wins this one, 7.3 to 6.5, above all for coverage in all 50 states, which most sellers will not confirm. Wisp undercuts it by $76 a month, so if the monthly bill is what decides it, Wisp is the pick. Wisp fits better if an oral route if you will not self-inject is your priority.
Choose Ivy Rx if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $175 a month.
Choose Wisp if…
You want an oral route if you will not self-inject and an opening price near $99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Ivy Rx vs Wisp: FAQ
Close alternatives to Ivy Rx and Wisp
- Ivy Rx vs DudeMeds
- Ivy Rx vs Curve
- Ivy Rx vs FitFlow
- Ivy Rx vs Genesis Health
- Wisp vs GobyMeds
- Wisp vs HeliMeds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.